Nauroz Khan (358)

B.B.A 8th

Subject

International Business

Teacher

Sir.Atiq Ali Babar

Presentation By

Slide Master

Introduction

• Founded in1849 by Charles Pfizer and Charles Erhardt.

• Headquarters are in New York City, with its research headquarters in Groton.

• Pfizer has its offices and operation in more than 150 countries.

• It has about 122,000 employees worldwide.

Executive Leadership Team

Ian Read Olivier Brandicourt President and President and General

Chief Executive Officer Manager, Primary Care

Frank D'Amelio Mikael Dolsten Executive Vice President, President, worldwide Chief Financial Officer and Research & Development Business Operations

Mission• To maximize new opportunities in

biomedical research, and bring more innovative medicines to more patients more quickly.

Vision• We will be recognized for meeting the

diverse medical needs of patients in Emerging Markets around the world in an innovative, socially responsible and commercially viable manner.

Pfizer RankMarch, 2011• Pfizer ranked first in the medicine and health care

industry in an annual ranking conducted by Antal International, a global executive search firm.

November, 2010• Pfizer ranked 21st of Top 500 US and 20th of Top 100

Global Green Companies by Newsweek.

Challenge• We bring the best scientific minds together to

challenge the most feared diseases of our time…

Pfizer Business• Pfizer is into 2 different businesses:

1) Consumer Health Care Products.

2) Animal Health Care Products.

Marketing• Pfizer markets it’s products via doctors

• Pfizer approaches doctors through medical representative.

• Company use to provide gifts to doctors on a sell of certain quantity pre-decided between company and doctors.

• Gives advertisement for general diseases like cholesterol, depression etc.

Specialized

• Immunology and inflammation, oncology, cardiovascular and metabolic diseases, neuroscience and pain, and vaccines. Through major research efforts across multiple modalities — including small molecules, biologics and vaccines.

Key Products• Aricept• Celebrex• Diflucan• Lipitor tablets• Neurontin• Norvasc • Xalatan • Zithromax • Zoloft • Zyrtec

Competitors

Social Responsibilities• Global Health Program

• Grants and Contribution

• Work with Health care Professionals

• Protecting the Environment

• Work place Responsibilities

Financial Data 2010 2009

In Millions

• Revenues $ 67,809 $ 50,009• Net Income $ 8,289 $ 8,644• EPS $ 1.03 $ 1.23

• Shares Registered in NYSE.

Merger• On January 26, 2009, US-based pharmaceutical major Pfizer

Incorporated (Pfizer) and one of its rival firms, US-based Wyeth, announced that they had entered into a merger agreement. The merger would make Pfizer the world's largest biopharmaceutical company.

Merger Cont…• As per the agreement, Pfizer would acquire Wyeth in a cash-

and-stock transaction. Pfizer agreed to pay a total of US$ 50.19 per share of Wyeth making the total deal worth approximately US$ 68 billion. The transaction between Pfizer and Wyeth would result in Wyeth stockholders holding a 16% equity stake in the combined entity in addition to the cash they would receive from Pfizer.

News & Media• Press Release

• Featured Stories

• Video Gallery

• Social Media etc.